There were 923 press releases posted in the last 24 hours and 190,834 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ligand Partner Travere Therapeutics Announces Positive Topline Interim Results from the Ongoing Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image